Where we only describe 1.5- to 2-fold increase in BCMA expression in CLL after 48 hours of γ-secretase inhibition, in multiple myeloma fold increases up to 10 times have been described already 4 hours after addition of γ-secretase inhibitors (38). The gene discussed is TNFRSF17; the disease is AL amyloidosis.